相关实验视频

Updated: Jul 5, 2025

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

CXCR4是抗HIV基因治疗的潜在目标

Appolinaria K Prokopovich¹, Irina S Litvinova¹, Alexandra E Zubkova^1,2

¹State Research Center of Virology and Biotechnology "Vector", Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being (FBRI SRC VB "Vector", Rospotrebnadzor), 630559 Koltsovo, Russia.

International journal of molecular sciences

|January 23, 2024

概括

基因疗法为治疗人类免疫缺陷病毒 (HIV) 提供了新的希望,通过阻止其进入细胞. 本综述分析了修改CXCR4核受体以有效的HIV基因治疗.

科学领域:

病毒学病毒学
基因治疗基因治疗
分子生物学分子生物学

背景情况:

全球人类免疫缺陷病毒 (HIV) 疫情影响着数百万人,目前的抗病毒疗法无法消除病毒.
基因疗法为艾滋病毒治疗提出了新的策略,重点是防止病毒进入宿主细胞.
现有的基因疗法方法针对CCR5核受体,但HIV也利用CXCR4核受体进入细胞.

研究的目的:

分析CXCR4核受体中的氨基酸及其生理配体和HIV gp120蛋白之间的相互作用.
为了确定基因治疗的潜在目标,旨在修改CXCR4以对抗艾滋病毒感染.
探索CXCR4的基因疗法策略,因为由于其生理重要性,标准淘汰赛是不可行的.

主要方法:

审查和分析有关HIV-1核受体相互作用的现有科学文献.
详细检查了CXCR4和HIV gp120.中特定氨基酸之间的分子相互作用.
基于对这些相互作用的分析,讨论潜在的基因疗法标.

主要成果:

该综述阐明了HIV gp120与CXCR4结合的特定氨基酸相互作用,这些相互作用对HIV gp120与CXCR4结合至关重要.
在CXCR4中确定了可以针对治疗修改的关键区域和氨基酸.
突出了通过基因疗法准CXCR4的可行性,与完全淘汰的局限性形成鲜明对比.

结论:

修改CXCR4核受体代表了开发针对HIV的新基因疗法的有希望的途径.
了解CXCR4的分子相互作用对于设计有效的基因干预措施至关重要.
向CXCR4提供了一个潜在的策略,可以补充基于CCR5的疗法,并扩大HIV基因治疗的范围.

关键词:

在CXCR4中,CXCR4是最常见的.艾滋病病毒艾滋病病毒艾滋病病毒基因治疗的基因疗法在 gp120 里面.

更多相关视频

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on: July 2, 2016

CRISPR-Cas9-based Genome Engineering to Generate Jurkat Reporter Models for HIV-1 Infection with Selected Proviral Integration Sites

CRISPR-Cas9-based Genome Engineering to Generate Jurkat Reporter Models for HIV-1 Infection with Selected Proviral Integration Sites

Published on: November 14, 2018

相关概念视频

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...